SCHEMBL9910288

SCHEMBL9910288

Cc1sc(-c2ccc(-c3ccccc3)cc2)nc1CCOc1ccc2c(c1)CCC2

nearest known ligand 0.65

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 19/20 0.65
PPARG P37231 19/20 0.65
PPARD Q03181 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10269918 0.98 PPARG (0.64) PPARAPPARG
SCHEMBL12646030 0.91 PPARA (0.63) PPARAPPARGPPARD
SCHEMBL12645358 0.90 PPARA (0.64) PPARAPPARGPPARD
SCHEMBL12646081 0.90 PPARA (0.64) PPARAPPARGPPARD
SCHEMBL10270289 0.89 PPARG (0.64) PPARAPPARG
SCHEMBL13972341 0.89 PPARA (0.64) PPARAPPARGPPARD
SCHEMBL13972056 0.88 PPARG (0.66) PPARAPPARG
SCHEMBL13972319 0.88 PPARG (0.66) PPARAPPARG
SCHEMBL10269688 0.88 PPARA (0.57) PPARAPPARGPPARD
SCHEMBL10269825 0.88 PPARA (0.65) PPARAPPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018102358-A1 METHODS OF TREATING OR PREVENTING COGNITIVE IMPAIRMENT USING INDANE ACETIC ACID DERIVATIVES BASED ON APOE4 GENOTYPE T3D THERAPEUTICS, INC. (US) 2018-06-07 WO disclosed
WO-2018102399-A1 METHODS OF DOSE ADMINISTRATION FOR TREATING OR PREVENTING COGNITIVE IMPAIRMENT USING INDANE ACETIC ACID DERIVATIVES T3D THERAPEUTICS, INC. (US) 2018-06-07 WO disclosed
WO-2012074980-A2 METHODS OF TREATING OR PREVENTING AUTOIMMUNE DISORDERS AND LIVER DISORDERS USING INDANE ACETIC ACID DERIVATIVES DARA BIOSCIENCES, INC. (US) 2012-06-07 WO disclosed
US-7476742-B2 Indane acetic acid derivatives and their use as pharmaceutical agents BAYER PHARMACEUTICALS CORPORATION (US) 2009-01-13 US disclosed